Norac Pharma
Norac Pharma is the pharmaceutical division of Norac, Inc., a privately held Azusa, California firm founded in 1966 that provides process R&D and cGMP API supply services to pharmaceutical clients, alongside a polymer additives division.
- Company typePrivate
- Founded1966
- HeadquartersAzusa, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Norac Pharma firmographics
Firmographics- Name
- Norac Pharma
- Legal name
- Norac, Inc.
- Website
- https://norac.com
- Company type
- Private
- Founded year
- 1966
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Norac Pharma is the pharmaceutical division of Norac, Inc., a privately held Azusa, California firm founded in 1966 that provides process R&D and cGMP API supply services to pharmaceutical clients, alongside a polymer additives division.
- Ownership category
- akta.pro rank
Norac Pharma industry classification
Industry- Product category
- Pharmaceutical API Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
- akta.pro secondary industries
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where Norac Pharma is headquartered
LocationHeadquarters
- HQ city
- Azusa
- HQ country
- United States
- HQ region
- North America
Markets served
Norac Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D
Norac Pharma product offering
Product offeringCore offering
Norac Pharma is a preclinical and cGMP manufacturing company that provides drug development services, API manufacturing, and preclinical supply to pharmaceutical customers. The company operates two divisions: Norac Pharma (process R&D and API supply) and Norac Additives (polymer additives).
Differentiator
Problem solved
Functional benefit
Products and services
- Norac Pharma (Process R&D and API Supply) Process research and development plus active pharmaceutical ingredient (API) manufacturing and supply under cGMP standards, targeted at pharmaceutical companies needing contract manufacturing and drug substance supply.
- Norac Additives Polymer additives manufacturing for industrial and chemical applications, serving customers in the polymer and specialty chemical markets.
Companies that use Norac Pharma
Customer profileIdeal customer profiles1 record
Norac Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Norac Pharma competitors and assessment
Company assessmentDirect peers
- Cambrex Corporation: Cambrex is a US-headquartered CDMO providing small-molecule API development and manufacturing services. It is a direct comparable to Norac Pharma in process R&D and cGMP API supply for pharmaceutical clients.
- Alcami Corporation: Alcami provides API development and manufacturing, analytical services, and drug product services to pharma and biotech clients. It is a direct comparable to Norac Pharma's small-molecule API offering.
- PCI Synthesis: PCI Synthesis is a US-based CDMO focused on small-molecule API development and manufacturing. As a mid-sized specialty CDMO serving similar pharma clients, it is a direct comparable to Norac Pharma.
- Hovione: Hovione is a privately held specialty CDMO offering integrated API development, scale-up, and commercial manufacturing. It directly competes with Norac Pharma in small-molecule process R&D and cGMP manufacturing.
- Curia (formerly AMRI): Curia is a CDMO offering contract research, API manufacturing, and drug product services. Its small-molecule API development and manufacturing business is closely comparable to Norac Pharma's core service.
Broad incumbents
- Johnson Matthey Pharma Services: Johnson Matthey operates a broad pharmaceutical services business covering APIs, catalysts, and drug delivery. Its API manufacturing and process development capabilities overlap with Norac Pharma's offerings as part of a much larger portfolio.
- Siegfried Holding: Siegfried is a publicly listed Swiss CDMO offering API and drug product manufacturing across a broad portfolio. As a larger, diversified incumbent, it overlaps with Norac Pharma's API manufacturing business but on a much wider scale.
- Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher's pharma services segment, is a leading global CDMO offering API and drug product services. Its scale and breadth make it a broad incumbent comparable to Norac Pharma's API work.
Emerging players
- Porton Pharma Solutions: Porton Pharma is a China-based CDMO offering API process development and manufacturing services. It is an emerging global player with overlapping capabilities to Norac Pharma, particularly in small-molecule API services.
- PharmaCore Inc. PharmaCore is a smaller US-based CDMO providing cGMP API manufacturing and custom synthesis. As a smaller emerging player, it is comparable in size and niche focus to Norac Pharma.
Market position
Customer concentration
Norac Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Norac Pharma leadership team
Management profileNumber of profiles
Norac Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Norac Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Norac Pharma
What does Norac Pharma do?
Norac Pharma is a preclinical and cGMP manufacturing company that provides drug development services, API manufacturing, and preclinical supply to pharmaceutical customers. The company operates two divisions: Norac Pharma (process R&D and API supply) and Norac Additives (polymer additives).
Is Norac Pharma a public or private company?
Norac Pharma is a private company. It is classified as unknown and is currently operating.
When was Norac Pharma founded?
Norac Pharma was founded in 1966. It employs 51 to 100 people.
Where is Norac Pharma based?
Norac Pharma is headquartered in Azusa, United States, in the North America region.
Who are Norac Pharma's main competitors?
Direct peers on record are Cambrex Corporation, Alcami Corporation, PCI Synthesis, Hovione and Curia (formerly AMRI). Broad incumbents are Johnson Matthey Pharma Services, Siegfried Holding and Patheon (Thermo Fisher Scientific). Emerging players are Porton Pharma Solutions and PharmaCore Inc..
Does Norac Pharma have an API?
No public API is recorded for Norac Pharma.
What industry is Norac Pharma in?
Norac Pharma's product category is Pharmaceutical API Manufacturing. Its primary akta.pro industry code is HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ), with a secondary code of HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 32541 and its SIC code is 2834.